Using stem cell-derived retinal ganglion cell transplants could restore vision lost due to glaucoma.

New center explores exciting possibilities for treating inherited retinal diseases that lead to blindness.

Glaucoma researchers at OHSU Casey Eye Institute work cooperatively to improve glaucoma care. 

Rare opportunity to study an inherited photoreceptor degeneration in a nonhuman primate model.

First to to deploy novel "spreading vector" technique in humans for X-linked juvenile retinoschisis.

Redefining the landscape with new techniques and clinical trials for corneal transplants.

A collaboration among OHSU cancer researchers reveals which cases of ocular melanoma are likely to spread.

Facial Nerve Center is the only place in Oregon to offer cutting edge facial reanimation surgery.

OHSU performs the first gene editing procedure in a living person in all of medicine using CRISPR technology.

Embedding clinical research in patient care leads to improvement in quality of life for patients.

OHSU Casey Eye Institute is ideally positioned to support gene therapy and its clinical trials.

OCT optoretinography (ORG) demonstrated its potential for revealing photoreceptor dysfunction in the macula.

The Oregon Vision Health Network is expanding our model of eye care from individual to population health.

Data-Driven Medicine: Diagnosing retinopathy of prematurity using artificial intelligence.

Data-Driven Medicine: Leading invention in AI, telemedicine and data analytics for ophthalmology.